CryoLife (NYSE: CRY) reported Q2 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $35.5 million versus the consensus estimate of $35.57 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.